Clinical course of percutaneous cholecystostomies: A cross-sectional study

• Published in: World journal of clinical cases 2020-03, Vol.8 (6), p.1033-1041
• Main Authors: Er, Sadettin, Berkem, Hüseyin, Özden, Sabri, Birben, Birkan, Çetinkaya, Erdinç, Tez, Mesut, Yüksel, Bülent Cavit
• Format: Article
• Language: English
• Subjects: Retrospective Study
• ISSN: 2307-8960; 2307-8960
• DOI: 10.12998/wjcc.v8.i6.1033

Although cholecystectomy is the standard treatment modality, it has been shown that perioperative mortality is approaching 19% in critical and elderly patients. Percutaneous cholecystostomy (PC) can be considered as a safer option with a significantly lower complication rate in these patients. To assess the clinical course of acute cholecystitis (AC) in patients we treated with PC. The study included 82 patients with Grade I, II or III AC according to the Tokyo Guidelines 2018 (TG18) and treated with PC. The patients' demographic and clinical features, laboratory parameters, and radiological findings were retrospectively obtained from their medical records. Eighty-two patients, 45 (54.9%) were male, and the median age was 76 (35-98) years. According to TG18, 25 patients (30.5%) had Grade I, 34 (41.5%) Grade II, and 23 (28%) Grade III AC. The American Society of Anesthesiologists (ASA) physical status score was III or more in 78 patients (95.1%). The patients, who had been treated with PC, were divided into two groups: discharged patients and those who died in hospital. The groups statistically significantly differed only concerning the ASA score ( = 0.0001) and WBCC ( = 0.025). Two months after discharge, two patients (3%) were readmitted with AC, and the intervention was repeated. Nine of the discharged patients (13.6%) underwent interval open cholecystectomy or laparoscopic cholecystectomy (8/1) within six to eight weeks after PC. The median follow-up time of these patients was 128 (12-365) wk, and their median lifetime was 36 (1-332) wk. For high clinical success in AC treatment, PC is recommended for high-risk patients with moderate-severe AC according to TG18, elderly patients, and especially those with ASA scores of ≥ III. According to our results, PC, a safe, effective and minimally invasive treatment, should be preferred in cases suffering from AC with high risk of mortality associated with cholecystectomy.